
SPDR Russell 2000 U.S. Small Cap UCITS ETF
SPDR Russell 2000 U.S. Small Cap UCITS ETF (SSEUF) Price & Chart
SSEUF ETF Chart & Stats
- Day’s Range
- $81.13 - $82.12
- 52-Week Range
- $67.20 - $89.90
- Previous Close
- $81.73
- Volume
- 4,207
- Average Volume (3M)
- 7,574
- AUM
- 4.66B
- NAV
- 81.64
- Expense Ratio
- 0.30%
- Holdings Count
- 1,910
- Beta
- 0.93
- Inception Date
- Jun 30, 2014
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 57,808,876
- Standard Deviation
- N/A
ETF Overview
SPDR Russell 2000 U.S. Small Cap UCITS ETF
The SPDR Russell 2000 U.S. Small Cap UCITS ETF (Ticker: SSEUF) is a compelling investment vehicle designed to capture the dynamic potential of America's small-cap companies. As a part of the Size and Style category with a specific focus on Small Cap equities, this ETF offers investors targeted exposure to the Russell 2000 Index, which is renowned for its comprehensive representation of U.S. small-cap stocks. Small-cap companies are often at the forefront of innovation and growth, providing a unique opportunity for investors seeking to diversify their portfolios with high-growth potential assets. This ETF stands out in the broad-based niche by enabling investors to tap into the collective strength of smaller enterprises across various sectors, potentially benefiting from their agility and capacity for rapid expansion. Managed under the trusted SPDR brand, known for its commitment to robust performance and risk management, the SSEUF is suitable for those looking to enhance their portfolio with a strategic allocation to small-cap stocks, often considered the engine room of the U.S. economy. Whether you're an institutional investor or a retail enthusiast, the SPDR Russell 2000 U.S. Small Cap UCITS ETF provides a streamlined and efficient means to access a vibrant segment of the market, poised for future growth and opportunity.
- Asset Class
- Equity
- Region
- North America
- Issuer
- SPDR
- Index Tracked
- Russell 2000
- Ticker Symbol
- SSEUF
SSEUF ETF News


Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: The official title is A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability,

Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: Vaxcyte’s Phase 3 study, officially titled “A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the
SSEUF ETF FAQ
What was SSEUF’s price range in the past 12 months?
What is the AUM of SSEUF?
Is SSEUF overvalued?
How many shares outstanding does SSEUF have?
SSEUF ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| GKOSGlaukos Corp. | 0.47% |
| BTSGBrightSpring Health Services, Inc. | 0.40% |
| FROGJfrog Ltd. | 0.40% |
| UMBFUmb Financial Corp. | 0.34% |
| VSATViaSat Inc | 0.33% |
| MOG.AMoog Inc. | 0.33% |
| TGTXTG Therapeutics | 0.31% |
| PCVXVaxcyte, Inc. | 0.31% |
| RHPRyman Hospitality Properties | 0.31% |
| CTRECareTrust REIT | 0.30% |
| Total | 3.52% |











